186
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Prognostic association of routinely measured biomarkers in patients admitted to critical care: a systematic review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1-12 | Received 29 Jul 2020, Accepted 18 Oct 2020, Published online: 05 Nov 2020

References

  • Altman, D.G., and Royston, P., 2000. What do we mean by validating a prognostic model? Statistics in medicine, 19 (4), 453–473.
  • Badrick, T., 2013. Evidence-based laboratory medicine. The clinical biochemist reviews, 34 (2), 43–46.
  • Bazick, H.S., et al., 2011. Red cell distribution width and all-cause mortality in critically ill patients. Critical Care Medicine, 39, 1913–1921.
  • Berger, M.L., et al., 2012. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. Value in health : the journal of the international society for pharmacoeconomics and outcomes research, 15 (2), 217–230.
  • Breslow, M.J., and Badawi, O., 2012a. Severity scoring in the critically ill: part 1-interpretation and accuracy of outcome prediction scoring systems. Chest, 141 (1), 245–252.
  • Breslow, M.J., and Badawi, O., 2012b. Severity scoring in the critically ill: part 2: maximizing value from outcome prediction scoring systems. Chest, 141 (2), 518–527.
  • Collins, G.S., et al., 2015. Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Journal of clinical epidemiology, 68 (2), 134–143.
  • Ezzie, M.E., Aberegg, S.K., and O'Brien, J.M., 2007. Laboratory testing in the intensive care unit. Critical care clinics, 23 (3), 435–465.
  • Gerlach, A.T., 2018. Sepsis Biomarkers…The Long and Winding Road. Critical care medicine, 46 (7), 1194–1195.
  • Gluck, E., et al., 2018. Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: a retrospective, observational study. PLoS one, 13 (10), e0205924.
  • Grimes, D.A., and Schulz, K.F., 2002. Bias and causal associations in observational research. Lancet (london, England), 359 (9302), 248–252.
  • Güell, E., et al., 2019. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock. Journal of clinical medicine, 8, 754.
  • Heilmann, E., Gregoriano, C., and Schuetz, P., 2019. Biomarkers of Infection: Are They Useful in the ICU? Seminars in respiratory and critical care medicine, 40 (4), 465–475.
  • Hermans, G., et al., 2019. Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study. Thorax, 74 (11), 1037–1045.
  • Hwang, S.Y., et al., 2017. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. The american journal of emergency medicine, 35 (2), 234–239.
  • Jeffcote, T., et al., 2019. Patient characteristics, ICU-specific supports, complications, and outcomes of persistent critical illness. Journal of critical care, 54, 250–255.
  • Kelly, B.J., Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program., et al., 2018. Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis. Critical care medicine, 46 (7), 1106–1113.
  • Kim, C.H., et al., 2013. An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shock. Critical care, 17 (6), R282.
  • Koyner, J.L., et al., 2019. The impact of biomarkers of acute kidney injury on individual patient care. Nephrol dial transplant, 35, 1295–1305.
  • Lederer, D.J., et al., 2019. Control of confounding and reporting of results in causal inference studies. guidance for authors from editors of respiratory, sleep, and critical care journals. Annals of the American thoracic society, 16 (1), 22–28.
  • Leisman, D.E., et al., 2020. Development and reporting of prediction models: guidance for authors from editors of respiratory, sleep, and critical care journals. Critical care medicine, 48 (5), 623–633.
  • Li, J., Gao, M., and D'Agostino, R., 2019. Evaluating classification accuracy for modern learning approaches. Statistics in medicine, 38 (13), 2477–2503.
  • Moher, D., et al.,; PRISMA Group. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine, 6 (7), e1000097.
  • Opal, S.M., and Wittebole, X., 2020. Biomarkers of Infection and Sepsis. Critical care clinics, 36 (1), 11–22.
  • Purtle, S.W., et al., 2014. The association of red cell distribution width at hospital discharge and out-of-hospital mortality following critical illness. Critical care medicine, 42, 918–929.
  • Shillan, D., et al., 2019. Use of machine learning to analyse routinely collected intensive care unit data: a systematic review. Critical care, 23 (1), 284.
  • Sjoding, M.W., and Cooke, C.R., 2015. Chronic critical illness: a growing legacy of successful advances in critical care*. Critical care medicine, 43 (2), 476–477.
  • Srisawat, N., and Kellum, J.A., 2020. The role of biomarkers in acute kidney injury. Critical care clinics, 36 (1), 125–140.
  • Textor, J., et al., 2016. Robust causal inference using directed acyclic graphs: the R package 'dagitty. International journal of epidemiology., 45, 1887–1894.
  • Tyler, P.D., et al., 2018. Assessment of intensive care unit laboratory values that differ from reference ranges and association with patient mortality and length of stay. JAMA network open, 1 (7), e184521.
  • Viglianti, E.M., Kruser, J.M., and Iwashyna, T., 2019. The heterogeneity of prolonged ICU hospitalisations. Thorax, 74 (11), 1015–1017.
  • Vincent, J.L., and Moreno, R., 2010. Clinical review: scoring systems in the critically ill. Critical Care, 14 (2), 207.
  • Vincent, J.L., and Teixeira, L., 2014. Sepsis biomarkers. Value and limitations. American journal of respiratory and critical care medicine, 190 (10), 1081–1082.
  • VON Elm, E., et al.,; STROBE Initiative. 2008. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Journal of clinical epidemiology, 61 (4), 344–349.
  • Ware, L.B., 2017. Biomarkers in critical illness: new insights and challenges for the future. American journal of respiratory and critical care medicine, 196 (8), 944–945.
  • Ware, L.B., et al.,; NHLBI ARDS Clinical Trials Network. 2010. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest, 137 (2), 288–296.
  • Wells, G., et al., 2013. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [Accessed 1 Jun 2020].
  • Wunsch, H., Linde-Zwirble, W.T., and Angus, D.C., 2006. Methods to adjust for bias and confounding in critical care health services research involving observational data. Journal of critical care, 21 (1), 1–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.